Effects of Different Crystalloid Solutions for Extra-corporeal Membrane Oxygenator (ECMO) Priming
- Conditions
- Acute Respiratory Failure
- Interventions
- Other: Priming of ECMO circuit with 0.9% NaClOther: Priming of ECMO circuit with Balanced SolutionOther: Priming of ECMO circuit with Ringer Lactate
- Registration Number
- NCT02609360
- Brief Summary
Crystalloid solutions modify acid-base equilibrium according to their electrolyte composition. Moreover, it has been suggested that these alterations are generated by the difference between the solution strong ion difference (SID) and the plasma bicarbonate level. An increased risk of acute kidney injury and renal replacement therapy has been associated to the infusion of chloride rich crystalloids. This study aims to compare, in patients with acute respiratory failure undergoing ECMO support, the effects on acid-base status and renal function of crystalloids commonly employed for circuit priming to a balanced solution created with a SID equal to patients' bicarbonate level.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 45
- Patients with Acute Respiratory Failure in need for ECMO treatment
- None
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 0.9% NaCl Priming of ECMO circuit with 0.9% NaCl Circuit priming will be performed with 0.9% NaCl solution Balanced Solution Priming of ECMO circuit with Balanced Solution Circuit priming will be performed with a Balanced Solution created by mixing 0.9% NaCl, Sodium bicarbonate (8.4%) and injectable sterile water, in order to obtain a solution with constant sodium concentration (140 mEq/l) and SID equal to patient's bicarbonate level. Ringer Lactate Priming of ECMO circuit with Ringer Lactate Circuit priming will be performed with Ringer Lactated
- Primary Outcome Measures
Name Time Method Variation in Acid-Base Equilibrium (Base Excess) First 24 hours after ECMO start
- Secondary Outcome Measures
Name Time Method Variation in Renal Function First 24 hours after ECMO start Variation in Acid-Base Equilibrium (pH) First 24 hours after ECMO start
Trial Locations
- Locations (1)
Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
🇮🇹Milan, Italy